Eledon Pharmaceuticals Inc (ELDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -35,170 | -17,711 | -6,495 | -36,184 | 8,433 |
| Depreciation Amortization | N/A | N/A | N/A | 359 | N/A |
| Income taxes - deferred | N/A | N/A | N/A | 431 | N/A |
| Accounts payable and accrued liabilities | N/A | 2,120 | -2,403 | 7,751 | N/A |
| Other Working Capital | 2,994 | 1,704 | -1,753 | 8,710 | 10,227 |
| Other Operating Activity | -16,074 | -19,886 | -5,409 | -28,338 | -46,944 |
| Operating Cash Flow | $-48,250 | $-33,773 | $-16,060 | $-47,271 | $-28,284 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 31,255 | 18,850 | 3,892 | -70,314 | -22,932 |
| Investing Cash Flow | $31,255 | $18,850 | $3,892 | $-70,314 | $-22,932 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 115 | 115 | 115 | 133,522 | 53,355 |
| Financing Cash Flow | $115 | $115 | $115 | $133,522 | $53,355 |
| Beginning Cash Position | 20,549 | 20,549 | 20,549 | 4,612 | 4,612 |
| End Cash Position | 3,669 | 5,741 | 8,496 | 20,549 | 6,751 |
| Net Cash Flow | $-16,880 | $-14,808 | $-12,053 | $15,937 | $2,139 |
| Free Cash Flow | |||||
| Operating Cash Flow | -48,250 | -33,773 | -16,060 | -47,271 | -28,284 |
| Free Cash Flow | -48,250 | -33,773 | -16,060 | -47,271 | -28,284 |